Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy [NA]

View source ↗

Summary

A recruiting study evaluating lean-mass preservation with resistance exercise and protein intake during combination semaglutide and tirzepatide therapy for obes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (tirzepatide)
  • semaglutide (semaglutide)

Snippet

Sponsor: Dasman Diabetes Institute | Conditions: Obesity | NA | Status: RECRUITING